Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study by Siqing Fu, Aung Naing, Filip Janku, Mingxuan Xu, Anas Alshawa, Nazanin Majd, Steven G Waguespack, Marta Penas-Prado, Carlos Kamiya-Matsuoka, Shaan M Raza, Ian E McCutcheon

Get full text

Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer by Afshin Dowlati, Judy Wang, Siqing Fu, Amita Patnaik, Minal Barve, Shivaani Kummar, Abdul Rafeh Naqash, Patricia LoRusso, Michael Gordon, Debra L Richardson, Ira Winer, Christos Kyriakopoulos, Joleen Hubbard, Marc Chamberlain, Oladapo O Yeku, Winston W Tan, Sarah K Lynam

Get full text

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer by Dmitriy Zamarin, Siqing Fu, Elad Sharon, Travis J Hollmann, Alexia Iasonos, Jason A Konner, Susan C Modesitt, Qin Zhou, Alexandre Buckley De Meritens, Carol Aghajanian, Claire F Friedman, Panagiotis A Konstantinopoulos, Bradley R Corr, Michael A Carducci, Alexandra Snyder Charen

Get full text

Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial by Mirella Nardo, Mohamed A. Gouda, Matthew J. Reilley, Amadeo B. Biter, Joann Lim, Stacie A. Bean, Ly M. Nguyen, Priya R. Bhosale, Casey R. Ager, Coline A. Couillault, Sarina A. Piha-Paul, Siqing Fu, Apostolia M. Tsimberidou, Timothy A. Yap, Aung Naing, Jordi Rodon, Vivek Subbiah, Daniel D. Karp, Michael A. Curran, David S. Hong

Get full text

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma by Omar Alhalabi, Mohamed A. Gouda, Denái R. Milton, Hassan Ahmed Momin, Bulent Yilmaz, Bettzy Stephen, Chinenye Lynette Ejezie, Justin Tyler Moyers, Serdar A. Gurses, Jeffrey How, Siqing Fu, Jordi Rodon, David S. Hong, Sarina A. Piha‐Paul, Vivek Subbiah, Ecaterina Elena Dumbrava, Daniel D. Karp, Filip Janku, Funda Meric‐Bernstam, Nizar M. Tannir, Aung Naing

Get full text

Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch re... by Heather Lin, Vivek Subbiah, Siqing Fu, Aung Naing, Courtney Nicholas, Shubham Pant, Chad Tang, Michael A Curran, David S Hong, Ying Yuan, Sarina A Piha-Paul, Jordi Rodon Ahnert, Timonthy A Yap, Apostolia M Tsimberidou, Daniel D Karp, Anupallavi Srinivasamani, Coline Couillault, Genevieve P Hartley, James Dai, Ecaterina E Ileana Dumbrava, Paola Guerrero, Sarah Dhebat, Theresa Proia

Get full text